Peter M. Chang

No. 201, Sec. 2, Shipai Road
Taipei, TNQ 11217, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications

Nicotine drives lung cancer progression by suppressing cuproptosis through the LIAS-DLAT axis and promoting M2 macrophage polarization.

Nicotine drives lung cancer progression by suppressing cuproptosis through the LIAS-DLAT axis and promoting M2 macrophage polarization.

Journal: Free radical biology & medicine
Published: April 23, 2026

Editorial: Deciphering macrophage polarization/transition in human inflammatory disease and cancer.

Editorial: Deciphering macrophage polarization/transition in human inflammatory disease and cancer.

Journal: Frontiers in immunology
Published: February 05, 2026

Multi-agent chemotherapy for refractory head and neck cancer.

Multi-agent chemotherapy for refractory head and neck cancer.

Journal: Journal of the Chinese Medical Association : JCMA
Published: January 08, 2026

Adjuvant metronomic tegafur-uracil is associated with poorer outcomes and unfavorable histopathologic progression in oral squamous cell carcinomas.

Adjuvant metronomic tegafur-uracil is associated with poorer outcomes and unfavorable histopathologic progression in oral squamous cell carcinomas.

Journal: Journal of dental sciences
Published: October 15, 2025

The new insights of surgery for locally advanced head and neck cancer.

The new insights of surgery for locally advanced head and neck cancer.

Journal: Expert review of anticancer therapy
Published: May 15, 2025

Targeting ESR1 restores SQSTM1-dependent autophagy and sensitizes ER-positive breast cancer to oxidative and radiation stress.

Targeting ESR1 restores SQSTM1-dependent autophagy and sensitizes ER-positive breast cancer to oxidative and radiation stress.

Journal: Cell death discovery
Published: April 29, 2025

Efficacy of adjuvant nivolumab in patients with upper tract predominant urothelial carcinoma: A single-center real-world study.

Efficacy of adjuvant nivolumab in patients with upper tract predominant urothelial carcinoma: A single-center real-world study.

Journal: Urologic oncology
Published: April 29, 2025

Correction: Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer.

Correction: Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer.

Journal: Cell death discovery
Published: April 25, 2025

Real-world experience in treatment outcome and genomic insights for metastatic prostate neuroendocrine carcinoma.

Real-world experience in treatment outcome and genomic insights for metastatic prostate neuroendocrine carcinoma.

Journal: Journal of the Chinese Medical Association : JCMA
Published: April 18, 2025

Nanoliposomal Irinotecan in Combination With 5-Fluorouracil and Leucovorin for Advanced Head and Neck and Esophageal Squamous Cell Carcinoma After Prior Platinum-Based Chemotherapy or Chemoradiotherapy: A Multicenter Phase II Trial.

Nanoliposomal Irinotecan in Combination With 5-Fluorouracil and Leucovorin for Advanced Head and Neck and Esophageal Squamous Cell Carcinoma After Prior Platinum-Based Chemotherapy or Chemoradiotherapy: A Multicenter Phase II Trial.

Journal: Cancer medicine
Published: January 21, 2025

Extracellular Vesicular Delta-Like Ligand 3 and Subtype Transcription Factors for Small Cell Lung Cancer Diagnosis.

Extracellular Vesicular Delta-Like Ligand 3 and Subtype Transcription Factors for Small Cell Lung Cancer Diagnosis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 11, 2024

Oral Cancer-Derived miR-762 Suppresses T-Cell Infiltration and Activation by Horizontal Inhibition of CXCR3 Expression.

Oral Cancer-Derived miR-762 Suppresses T-Cell Infiltration and Activation by Horizontal Inhibition of CXCR3 Expression.

Journal: International journal of molecular sciences
Published: November 11, 2024
Showing 1-12 of 84

Last Updated: 09/26/2026